North America Hyaluronic Acid Market Size & Outlook
The hyaluronic acid market in North America is expected to reach a projected revenue of US$ 8,470.7 million by 2033. A compound annual growth rate of 6.9% is expected of North America hyaluronic acid market from 2026 to 2033.
Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology
Other key industry trends
In terms of revenue, North America region accounted for 43.0% of the global hyaluronic acid market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 5,144.8 million by 2033.
Viscosupplements for the treatment of osteoarthritis and soft tissue dermal fillers are witnessing high demand in North America. This can be attributed to greater preference for minimally invasive and shortduration treatment regimens in the U.S. & Canada.
According to morbidity and mortality report published by the CDC, 58.9% of the U.S. population suffers from some form of arthritis. Thus, increasing prevalence of osteoarthritis and growing preference for minimally invasive procedures are among factors fueling market growth in North America.
Hyaluronic acid-based dermal filler procedures are gaining popularity in North America. According to the ISAPS, 807,870 million hyaluronic acid procedures were performed in the U.S. in 2020. Hyaluronic acid dermal fillers are utilized for the correction of aging signs, skin contouring, reduction of depressions, and lip & cheek augmentation.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Hyaluronic Acid Market Outlook will help companies and investors design strategic landscapes.
Dermal Fillers was the largest segment with a revenue share of 55.16% in 2025.
Horizon Databook has segmented the North America hyaluronic acid market based on dermal fillers, vesicoureteral reflux, osteoarthritis, ophthalmic covering the revenue growth of each sub-segment from 2021 to 2033.
Viscosupplements for the treatment of osteoarthritis and soft tissue dermal fillers are witnessing high demand in North America. This can be attributed to greater preference for minimally invasive and shortduration treatment regimens in the U.S. & Canada.
According to morbidity and mortality report published by the CDC, 58.9% of the U.S. population suffers from some form of arthritis. Thus, increasing prevalence of osteoarthritis and growing preference for minimally invasive procedures are among factors fueling market growth in North America.
Hyaluronic acid-based dermal filler procedures are gaining popularity in North America. According to the ISAPS, 807,870 million hyaluronic acid procedures were performed in the U.S. in 2020. Hyaluronic acid dermal fillers are utilized for the correction of aging signs, skin contouring, reduction of depressions, and lip & cheek augmentation.
North America Hyaluronic Acid Market Application Outlook (Revenue, USD Million , 2021-2033)
Dermal Fillers
Osteoarthritis
Ophthalmic
Vesicoureteral Reflux
Reasons to subscribe to Hyaluronic Acid Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Hyaluronic Acid Market Outlook databook
Our clientele includes a mix of Hyaluronic Acid Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Hyaluronic Acid Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Hyaluronic Acid Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Hyaluronic Acid Market, 2021-2033 (US$M)